371 related articles for article (PubMed ID: 25344861)
1. Glycogen synthase kinase-3β inhibition depletes the population of prostate cancer stem/progenitor-like cells and attenuates metastatic growth.
Kroon J; in 't Veld LS; Buijs JT; Cheung H; van der Horst G; van der Pluijm G
Oncotarget; 2014 Oct; 5(19):8986-94. PubMed ID: 25344861
[TBL] [Abstract][Full Text] [Related]
2. Glycogen synthase kinase--3β inhibitors suppress leukemia cell growth.
Song EY; Palladinetti P; Klamer G; Ko KH; Lindeman R; O'Brien TA; Dolnikov A
Exp Hematol; 2010 Oct; 38(10):908-921.e1. PubMed ID: 20540984
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of GSK-3 beta activity attenuates proliferation of human colon cancer cells in rodents.
Shakoori A; Mai W; Miyashita K; Yasumoto K; Takahashi Y; Ooi A; Kawakami K; Minamoto T
Cancer Sci; 2007 Sep; 98(9):1388-93. PubMed ID: 17640304
[TBL] [Abstract][Full Text] [Related]
4. NOR1 Suppresses Cancer Stem-Like Cells Properties of Tumor Cells via the Inhibition of the AKT-GSK-3β-Wnt/β-catenin-ALDH1A1 Signal Circuit.
Wang W; Yi M; Chen S; Li J; Zhang H; Xiong W; Li G; Li X; Xiang B
J Cell Physiol; 2017 Oct; 232(10):2829-2840. PubMed ID: 27891591
[TBL] [Abstract][Full Text] [Related]
5. Distinct expression and activity of GSK-3α and GSK-3β in prostate cancer.
Darrington RS; Campa VM; Walker MM; Bengoa-Vergniory N; Gorrono-Etxebarria I; Uysal-Onganer P; Kawano Y; Waxman J; Kypta RM
Int J Cancer; 2012 Sep; 131(6):E872-83. PubMed ID: 22539113
[TBL] [Abstract][Full Text] [Related]
6. Embelin-Induced Apoptosis of Human Prostate Cancer Cells Is Mediated through Modulation of Akt and β-Catenin Signaling.
Park N; Baek HS; Chun YJ
PLoS One; 2015; 10(8):e0134760. PubMed ID: 26252009
[TBL] [Abstract][Full Text] [Related]
7. The miR-203/SNAI2 axis regulates prostate tumor growth, migration, angiogenesis and stemness potentially by modulating GSK-3β/β-CATENIN signal pathway.
Tian X; Tao F; Zhang B; Dong JT; Zhang Z
IUBMB Life; 2018 Mar; 70(3):224-236. PubMed ID: 29389061
[TBL] [Abstract][Full Text] [Related]
8. Glycogen synthase kinase-3beta inhibition preserves hematopoietic stem cell activity and inhibits leukemic cell growth.
Holmes T; O'Brien TA; Knight R; Lindeman R; Shen S; Song E; Symonds G; Dolnikov A
Stem Cells; 2008 May; 26(5):1288-97. PubMed ID: 18323411
[TBL] [Abstract][Full Text] [Related]
9. GSK-3β suppresses the proliferation of rat hepatic oval cells through modulating Wnt/β-catenin signaling pathway.
Ji XK; Xie YK; Zhong JQ; Xu QG; Zeng QQ; Wang Y; Zhang QY; Shan YF
Acta Pharmacol Sin; 2015 Mar; 36(3):334-42. PubMed ID: 25661318
[TBL] [Abstract][Full Text] [Related]
10. Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancer.
Liao X; Thrasher JB; Holzbeierlein J; Stanley S; Li B
Endocrinology; 2004 Jun; 145(6):2941-9. PubMed ID: 14988390
[TBL] [Abstract][Full Text] [Related]
11. GSK-3β controls autophagy by modulating LKB1-AMPK pathway in prostate cancer cells.
Sun A; Li C; Chen R; Huang Y; Chen Q; Cui X; Liu H; Thrasher JB; Li B
Prostate; 2016 Feb; 76(2):172-83. PubMed ID: 26440826
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of cytoplasmic GSK-3β increases cisplatin resistance through activation of Wnt/β-catenin signaling in A549/DDP cells.
Gao Y; Liu Z; Zhang X; He J; Pan Y; Hao F; Xie L; Li Q; Qiu X; Wang E
Cancer Lett; 2013 Aug; 336(1):231-9. PubMed ID: 23673211
[TBL] [Abstract][Full Text] [Related]
13. Glycogen synthase kinase-3beta positively regulates the proliferation of human ovarian cancer cells.
Cao Q; Lu X; Feng YJ
Cell Res; 2006 Jul; 16(7):671-7. PubMed ID: 16788573
[TBL] [Abstract][Full Text] [Related]
14. Aberrant nuclear accumulation of glycogen synthase kinase-3beta in human pancreatic cancer: association with kinase activity and tumor dedifferentiation.
Ougolkov AV; Fernandez-Zapico ME; Bilim VN; Smyrk TC; Chari ST; Billadeau DD
Clin Cancer Res; 2006 Sep; 12(17):5074-81. PubMed ID: 16951223
[TBL] [Abstract][Full Text] [Related]
15. Aquaporin 3 promotes the stem-like properties of gastric cancer cells via Wnt/GSK-3β/β-catenin pathway.
Zhou Y; Wang Y; Wen J; Zhao H; Dong X; Zhang Z; Wang S; Shen L
Oncotarget; 2016 Mar; 7(13):16529-41. PubMed ID: 26918728
[TBL] [Abstract][Full Text] [Related]
16. Glycogen synthase kinase-3beta: a prognostic marker and a potential therapeutic target in human bladder cancer.
Naito S; Bilim V; Yuuki K; Ugolkov A; Motoyama T; Nagaoka A; Kato T; Tomita Y
Clin Cancer Res; 2010 Nov; 16(21):5124-32. PubMed ID: 20889919
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of glycogen synthase kinase-3β counteracts ligand-independent activity of the androgen receptor in castration resistant prostate cancer.
Schütz SV; Schrader AJ; Zengerling F; Genze F; Cronauer MV; Schrader M
PLoS One; 2011; 6(9):e25341. PubMed ID: 21980429
[TBL] [Abstract][Full Text] [Related]
18. Glycogen synthase kinase-3 beta inhibitor suppresses Porphyromonas gingivalis lipopolysaccharide-induced CD40 expression by inhibiting nuclear factor-kappa B activation in mouse osteoblasts.
Die L; Yan P; Jun Jiang Z; Min Hua T; Cai W; Xing L
Mol Immunol; 2012 Aug; 52(1):38-49. PubMed ID: 22580404
[TBL] [Abstract][Full Text] [Related]
19. Anticancer efficacy of deguelin in human prostate cancer cells targeting glycogen synthase kinase-3 β/β-catenin pathway.
Thamilselvan V; Menon M; Thamilselvan S
Int J Cancer; 2011 Dec; 129(12):2916-27. PubMed ID: 21472727
[TBL] [Abstract][Full Text] [Related]
20. Novel indolylmaleimide acts as GSK-3beta inhibitor in human neural progenitor cells.
Schmöle AC; Brennführer A; Karapetyan G; Jaster R; Pews-Davtyan A; Hübner R; Ortinau S; Beller M; Rolfs A; Frech MJ
Bioorg Med Chem; 2010 Sep; 18(18):6785-95. PubMed ID: 20708937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
